The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
NeoImmuneTech
Neonc Technologies, Inc.
AstraZeneca
Radiopharm Theranostics, Ltd
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
Marengo Therapeutics, Inc.
Klus Pharma Inc.
National Institutes of Health Clinical Center (CC)
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Sellas Life Sciences Group
Salubris Biotherapeutics Inc
Cancer Research and Biostatistics Clinical Trials Consortium
Evopoint Biosciences Inc.
Incyte Corporation
Gilead Sciences
MEI Pharma, Inc.
Amgen